• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

探讨循环长链非编码 RNA 在乳腺癌中的临床潜力:原发性信号通路和治疗干预的新见解。

Exploring the clinical potential of circulating LncRNAs in breast cancer: insights into primary signaling pathways and therapeutic interventions.

机构信息

Department of Biochemistry, Faculty of Pharmacy, Heliopolis University, Cairo, 11785, Egypt.

Biochemistry and Molecular Biology Department, Faculty of Pharmacy (Girls), Al-Azhar University, Nasr City, Cairo, 11823, Egypt.

出版信息

Funct Integr Genomics. 2024 Nov 7;24(6):209. doi: 10.1007/s10142-024-01476-y.

DOI:10.1007/s10142-024-01476-y
PMID:39508907
Abstract

Breast cancer (BC) occupies the top spot among women on a global scale. The tumor has a significant degree of heterogeneity, displaying a notable prevalence of medication resistance, recurrence, and metastasis, rendering it one of the most lethal forms of malignant neoplasms. The timely identification, ongoing evaluation of therapeutic interventions, and accurate prediction of outcomes play crucial roles in determining the overall survival rates of women with BC. Nevertheless, the absence of precise biomarkers remains a significant determinant impacting the overall well-being and both the physical and emotional health of BC patients. Long noncoding RNA (lncRNA) exerts regulatory control over several genes and signaling pathways, hence assuming crucial roles in the development of neoplastic growth. Recently, research has indicated that the atypical expression of circulating lncRNAs in various biological bodily fluids has a noteworthy impact on the early detection, pathological categorization, staging, monitoring of therapy outcomes, and evaluation of prognosis in cases of BC. This article aims to assess the potential clinical utility of circulating lncRNAs in the context of BC focusing on specific primary signaling pathways; Wnt/β-catenin, Notch, TGF-β, and hedgehog (Hh), in addition to some therapeutic interventions.

摘要

乳腺癌(BC)在全球范围内位居女性之首。肿瘤具有显著的异质性,表现出明显的药物耐药性、复发和转移,是最致命的恶性肿瘤之一。及时识别、持续评估治疗干预措施以及准确预测结果对于确定 BC 女性的总体生存率至关重要。然而,缺乏精确的生物标志物仍然是影响 BC 患者整体健康状况以及身心健康的重要决定因素。长链非编码 RNA(lncRNA)对多个基因和信号通路进行调控,因此在肿瘤生长的发展中起着关键作用。最近的研究表明,各种生物体液中循环 lncRNA 的异常表达对 BC 的早期检测、病理分类、分期、治疗效果监测和预后评估具有重要意义。本文旨在评估循环 lncRNA 在 BC 中的潜在临床应用价值,重点关注特定的主要信号通路;Wnt/β-catenin、Notch、TGF-β 和 hedgehog(Hh),以及一些治疗干预措施。

相似文献

1
Exploring the clinical potential of circulating LncRNAs in breast cancer: insights into primary signaling pathways and therapeutic interventions.探讨循环长链非编码 RNA 在乳腺癌中的临床潜力:原发性信号通路和治疗干预的新见解。
Funct Integr Genomics. 2024 Nov 7;24(6):209. doi: 10.1007/s10142-024-01476-y.
2
Unveiling the connection: Long-chain non-coding RNAs and critical signaling pathways in breast cancer.揭示关联:长链非编码 RNA 与乳腺癌关键信号通路
Pathol Res Pract. 2023 Sep;249:154736. doi: 10.1016/j.prp.2023.154736. Epub 2023 Aug 3.
3
Oncogenic signaling pathway-related long non-coding RNAs for predicting prognosis and immunotherapy response in breast cancer.用于预测乳腺癌预后和免疫治疗反应的致癌信号通路相关长链非编码RNA
Front Immunol. 2022 Aug 4;13:891175. doi: 10.3389/fimmu.2022.891175. eCollection 2022.
4
New insights into long non-coding RNAs in breast cancer: Biological functions and therapeutic prospects.长非编码 RNA 在乳腺癌中的新见解:生物学功能与治疗前景。
Exp Mol Pathol. 2021 Jun;120:104640. doi: 10.1016/j.yexmp.2021.104640. Epub 2021 Apr 17.
5
Systematic analysis of lncRNA-miRNA-mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer.系统分析 lncRNA-miRNA-mRNA 竞争内源性 RNA 网络鉴定出四个 lncRNA 特征作为乳腺癌的预后生物标志物。
J Transl Med. 2018 Sep 27;16(1):264. doi: 10.1186/s12967-018-1640-2.
6
Long noncoding RNAs as regulators of epithelial mesenchymal transition in breast cancer: A recent review.长链非编码 RNA 作为乳腺癌上皮间质转化的调控因子:最新综述。
Life Sci. 2024 Jan 1;336:122339. doi: 10.1016/j.lfs.2023.122339. Epub 2023 Dec 12.
7
Regulatory and therapeutic implications of competing endogenous RNA network in breast cancer progression and metastasis: A review.竞争性内源性RNA网络在乳腺癌进展和转移中的调控及治疗意义:综述
Int J Biol Macromol. 2024 May;266(Pt 2):131075. doi: 10.1016/j.ijbiomac.2024.131075. Epub 2024 Mar 24.
8
Long non-coding RNA LINC01287 promotes breast cancer cells proliferation and metastasis by activating Wnt/ß-catenin signaling.长链非编码RNA LINC01287通过激活Wnt/β-连环蛋白信号通路促进乳腺癌细胞的增殖和转移。
Eur Rev Med Pharmacol Sci. 2019 May;23(10):4234-4242. doi: 10.26355/eurrev_201905_17928.
9
Identification and validation of an epigenetically regulated long noncoding RNA model for breast cancer metabolism and prognosis.鉴定和验证乳腺癌代谢和预后的一个受表观遗传调控的长非编码 RNA 模型。
BMC Med Genomics. 2022 May 7;15(1):105. doi: 10.1186/s12920-022-01256-2.
10
A systematic review of long non-coding RNAs with a potential role in breast cancer.长非编码 RNA 在乳腺癌中潜在作用的系统评价。
Mutat Res Rev Mutat Res. 2021 Jan-Jun;787:108375. doi: 10.1016/j.mrrev.2021.108375. Epub 2021 Apr 16.

本文引用的文献

1
The RUNX Family of Proteins, DNA Repair, and Cancer.RUNX 蛋白家族、DNA 修复与癌症
Cells. 2023 Apr 7;12(8):1106. doi: 10.3390/cells12081106.
2
LncRNA PNKY Is Upregulated in Breast Cancer and Promotes Cell Proliferation and EMT in Breast Cancer Cells.长链非编码RNA PNKY在乳腺癌中上调并促进乳腺癌细胞的增殖和上皮-间质转化。
Noncoding RNA. 2023 Apr 6;9(2):25. doi: 10.3390/ncrna9020025.
3
HOTAIR: a potential metastatic, drug-resistant and prognostic regulator of breast cancer.HOTAIR:一种潜在的转移性、耐药性和乳腺癌预后调节因子。
Mol Cancer. 2023 Mar 30;22(1):65. doi: 10.1186/s12943-023-01765-3.
4
Glycolysis-related lncRNA TMEM105 upregulates LDHA to facilitate breast cancer liver metastasis via sponging miR-1208.糖酵解相关 lncRNA TMEM105 通过海绵吸附 miR-1208 上调 LDHA 促进乳腺癌肝转移。
Cell Death Dis. 2023 Feb 3;14(2):80. doi: 10.1038/s41419-023-05628-z.
5
Effect of long noncoding RNA CCAT2 on drug sensitivity to 5-fluorouracil of breast cancer cells through microRNA-145 meditated by p53.长链非编码 RNA CCAT2 通过 p53 调控 microRNA-145 对乳腺癌细胞 5-氟尿嘧啶敏感性的影响。
J Biochem Mol Toxicol. 2022 Nov;36(11):e23176. doi: 10.1002/jbt.23176. Epub 2022 Aug 15.
6
Long noncoding RNA ST8SIA6-AS1 promotes cell proliferation and metastasis in triple-negative breast cancer by targeting miR-145-5p/CDCA3 to inactivate the p53/p21 signaling pathway.长链非编码 RNA ST8SIA6-AS1 通过靶向 miR-145-5p/CDCA3 来抑制 p53/p21 信号通路,从而促进三阴性乳腺癌细胞的增殖和转移。
Environ Toxicol. 2022 Oct;37(10):2398-2411. doi: 10.1002/tox.23605. Epub 2022 Jun 22.
7
Statistics and network-based approaches to identify molecular mechanisms that drive the progression of breast cancer.统计和基于网络的方法,用于识别推动乳腺癌进展的分子机制。
Comput Biol Med. 2022 Jun;145:105508. doi: 10.1016/j.compbiomed.2022.105508. Epub 2022 Apr 14.
8
The potential of long noncoding RNA therapies.长非编码 RNA 疗法的潜力。
Trends Pharmacol Sci. 2022 Apr;43(4):269-280. doi: 10.1016/j.tips.2022.01.008. Epub 2022 Feb 10.
9
Hypoxia-induced lncRNA RBM5-AS1 promotes tumorigenesis via activating Wnt/β-catenin signaling in breast cancer.低氧诱导的长链非编码 RNA RBM5-AS1 通过激活乳腺癌中的 Wnt/β-连环蛋白信号通路促进肿瘤发生。
Cell Death Dis. 2022 Feb 2;13(2):95. doi: 10.1038/s41419-022-04536-y.
10
Long intergenic non-protein coding RNA 1094 (LINC01094) promotes the progression of breast cancer (BC) by regulating the microRNA-340-5p (miR-340-5p)/E2F transcription factor 3 (E2F3) axis.长链非编码 RNA 1094(LINC01094)通过调节 microRNA-340-5p(miR-340-5p)/E2F 转录因子 3(E2F3)轴促进乳腺癌(BC)的进展。
Bioengineered. 2021 Dec;12(1):9046-9057. doi: 10.1080/21655979.2021.1993715.